HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
92.0%
Total 13F principal
$376,464,592
Principal change
+$15,200,682
Total reported market value
$347,184,000
Number of holders
35
Value change
+$13,930,916
Number of buys
13
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q1 2018

As of 31 Mar 2018, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 35 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $376,464,592 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), OAKTREE CAPITAL MANAGEMENT LP, ADVENT CAPITAL MANAGEMENT /DE/, CANYON CAPITAL ADVISORS LLC, Linden Advisors LP, PRUDENTIAL PLC, Lion Point Capital, LP, SYMPHONY ASSET MANAGEMENT LLC, SILVERBACK ASSET MANAGEMENT LLC, and STATE STREET CORP. This page lists 35 institutional bondholders reporting positions for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.